Compare Docusign Inc (DOCU) vs Xylem, Inc. (XYL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Docusign Inc vs Xylem, Inc. — how do they compare? Docusign Inc trades at $71.08 (market cap $13.35B), while Xylem, Inc. trades at $102.71 (market cap $23.81B). The key difference: Xylem, Inc. is the larger of the two by market cap, and Xylem, Inc. pays a 1.69% dividend while Docusign Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Docusign Inc for 71 Days and Xylem, Inc. for 50 Days on average.
| DOCU | XYL | |
|---|---|---|
Market Cap | $13.35B | $23.81B |
Volume | 3,158,858 | 2,234,713 |
Sector | Technology | Industrials |
52-Week High | $73.14 | $152.95 |
52-Week Low | $41.75 | $100.92 |
Typical Hold Time | 71 Days | 50 Days |
Enterprise Value | $12.76B | $25.59B |
Dividend Yield | — | 1.69% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DOCU trades at $71.43, up 3.67% with strong technical momentum and bullish moving averages. The company demonstrates robust revenue growth, improving from $2.1B in 2022 to $3.0B in 2025, with net income turning positive at $1.07B. Recent earnings beats and AI-driven contract processing capabilities support the bullish case, though valuation multiples remain elevated with a P/E of 43.55.
Outlook remains positive with continued earnings momentum and AI integration driving efficiency, but risks include insider selling activity and competitive pressures in the e-signature market. Analyst consensus is cautious with 64% hold ratings, though technical indicators suggest near-term strength with support at $70 and resistance at $72.
Xylem (XYL) trades at $101.99, up 0.16% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.46 surpassing the $1.35 estimate. Revenue grew to $9.04B in 2025, and net income margin improved to 10.59%. Recent developments include a $1.5B senior note offering to fund acquisitions and the appointment of a new CFO.
The outlook is supported by solid fundamentals and analyst optimism, with a consensus price target of $149.13 implying significant upside. However, risks include China market weakness and higher debt from recent acquisitions. The stock offers a dividend yield with a $0.43 per share payout declared for Q3 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Docusign Inc
DocuSign offers the Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its IPO in May 2018.
Read more on DOCU →About Xylem, Inc.
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.
Read more on XYL →
